AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,802,540 | -69.9% | 39,000 | -67.7% | 0.01% | -76.9% |
| Q4 2022 | $9,323,012 | +422.3% | 120,874 | +202.2% | 0.03% | +420.0% |
| Q3 2022 | $1,785,000 | -53.4% | 40,000 | -60.0% | 0.01% | -58.3% |
| Q2 2022 | $3,830,000 | +161.1% | 100,000 | +124.7% | 0.01% | +100.0% |
| Q3 2021 | $1,467,000 | -71.9% | 44,509 | -39.3% | 0.01% | -84.2% |
| Q3 2020 | $5,220,000 | +15252.9% | 73,268 | +421.5% | 0.04% | – |
| Q1 2018 | $34,000 | – | 14,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |